MedPath

Combination of Psychosocial Intervention and Slow Prosecutions for the Treatment of Methamphetamine Abuse/Dependence

Not Applicable
Conditions
Amphetamine Abuse
Amphetamine Dependence
Methamphetamine Abuse
Methamphetamine Dependence
Registration Number
NCT01273701
Lead Sponsor
National Taiwan University Hospital
Brief Summary

The hospital where this study will be conducted is responsible for the one-year contingency management treatment for methamphetamine drug offenders referred from the Yunlin District Prosecutors Office. Completing the one-year treatment is prerequisite for offenders to get slow prosecutions.

It is an open-label, parallel-group trial comparing the combination of psychosocial intervention and slow prosecutions with psychosocial intervention alone in treating subjects with methamphetamine dependence

Study Hypothesis

1. Psychosocial interventions in combination with slow prosecutions is more effective than psychosocial interventions alone to achieve abstinence for subjects with methamphetamine abuse/dependance.

2. Inclusion of telephone reminding before each visit will enhance the retention rate and abstinence rate.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria
  • DSM-IV-TR criteria for amphetamine/methamphetamine abuse or dependence
  • 18 - 65 years old
  • For TSTSU-N and TSTSU-T arms: methamphetamine offenders referred by the Yunlin District Prosecutors Office
  • For OPD arm: psychiatric outpatients referred from the psychiatry clinics in National Taiwan University Hospital, Yunlin Branch
Exclusion Criteria
  • Concurrent use of other illicit substances
  • Co-morbidity with major psychotic disorders (schizophrenia, schizoaffective disorder, other psychotic disorder), mental retardation, acute episodes of major depressive disorder or bipolar affective disorder) or serious personality disorders.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Endpoint abstinence rateAt the end of one-year treatment

According to the urine amphetamine/methamphetamine screen after the one-year treatment, negative result suggests successful abstinence.

Secondary Outcome Measures
NameTimeMethod
Retention rateduring the whole one-year treatment

proportion of subjects who can complete the course of one-year treatment

Length of retentionduring the whole one-year treatment

the averaged duration of attending treatment

The longest period of abstinenceduring the whole one-year treatment

the longest period of time with successive negative results of urine amphetamine/methamphetamine tests or negative reports of recent methamphetamine use

Trial Locations

Locations (1)

National Taiwan University Hospital Yunlin Branch

🇨🇳

Yunlin, Taiwan

National Taiwan University Hospital Yunlin Branch
🇨🇳Yunlin, Taiwan
Yi-Ting Lin, M.D.
Principal Investigator
Li-Ren Chang, M.D.
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.